Life Sciences and AI: A Team-Up for the Future

Bayer AG, a leading name in pharmaceuticals and life sciences, is collaborating with Celonis SE to enhance operational efficiency through process intelligence and AI.

Beyond Technology: A Cultural Shift

This partnership isn't just about adopting new technology. It's about transforming how people work and think.

Timo Peters, the head of process insights at Bayer, shared insights at Celosphere 25. He emphasized that the goal isn't just cost savings—it's about improving the experience for those using these tools. He believes technology can drive change, but the right mindset and culture are what make it sustainable.

Managing Change and AI

Peters highlighted the importance of managing change when introducing new technology. While AI is powerful, it must be controlled. Process mining plays a crucial role here, ensuring AI operates as intended.

A Longstanding Collaboration

Bayer was one of Celonis's first customers and is now recognized as a 2023 Celonis Champion. Peters believes such collaborations are essential, as no single entity can achieve success alone. In the life sciences industry, shared goals allow companies to support each other.